Chemie IOCB News
DFG-Funding for CeBiTec-research with Technical University of Hamburg towards a biocatalytic sustainable synthesis of pharma-related β-hydroxy α-amino acids
Enantiomerically pure α-amino acids play an important role in today’s pharmaceutical industry since these compounds serve as valuable chiral key building blocks for the synthesis of modern active pharmaceutical ingredients. Many of them are already produced by means of biocatalysis. However, the access to more complex, non-proteinogenic β-hydroxy substituted α-amino acids bearing two stereogenic centers, which are of interest for production of a range of pharmaceuticals such as antibiotics, still represents a challenge and a biocatalytic approach to those molecules on large industrial scale has not been realized yet. This “white spot” on the “map of enzymatically produced amino acids” is now to be targeted jointly by the Institute of Technical Biocatalysis (ITB) at Hamburg University of Technology being headed by Professor Dr. Andreas Liese and the Chair of Industrial Organic Chemistry and Biotechnology (IOCB) at Bielefeld University headed by Prof. Dr. Harald Gröger as CeBiTec member in a research project funded by the German Research Foundation (DFG). The two research groups are collaborating intensively since more than a decade on various research topics in the field of biocatalysis and sustainable organic synthesis.